Improving the quality of life during chemotherapy for advanced breast cancer A Coates, V Gebski, JF Bishop, PN Jeal, RL Woods, R Snyder, ... New England Journal of Medicine 317 (24), 1490-1495, 1987 | 647 | 1987 |
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials BC Pestalozzi, D Zahrieh, E Mallon, BA Gusterson, KN Price, RD Gelber, ... Journal of clinical oncology 26 (18), 3006-3014, 2008 | 507 | 2008 |
Supportive‐expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial DW Kissane, B Grabsch, DM Clarke, GC Smith, AW Love, S Bloch, ... Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2007 | 486 | 2007 |
Patterns of recurrence and outcome according to breast cancer subtypes in lymph node–negative disease: results from International Breast Cancer Study Group Trials VIII and IX O Metzger-Filho, Z Sun, G Viale, KN Price, D Crivellari, RD Snyder, ... Journal of clinical oncology 31 (25), 3083, 2013 | 408 | 2013 |
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience G Berclaz, S Li, KN Price, AS Coates, M Castiglione-Gertsch, ... Annals of Oncology 15 (6), 875-884, 2004 | 348 | 2004 |
Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey B Grabsch, DM Clarke, A Love, DP McKENZIE, RD Snyder, S Bloch, ... Palliative & supportive care 4 (1), 47-56, 2006 | 246 | 2006 |
Effect of cognitive-existential group therapy on survival in early-stage breast cancer DW Kissane, A Love, A Hatton, S Bloch, G Smith, DM Clarke, P Miach, ... Journal of clinical oncology 22 (21), 4255-4260, 2004 | 234 | 2004 |
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group. JA Levi, D Raghavan, V Harvey, D Thompson, T Sandeman, G Gill, ... Journal of clinical oncology 11 (7), 1300-1305, 1993 | 184 | 1993 |
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience M Colleoni, D Zahrieh, RD Gelber, SB Holmberg, JE Mattsson, ... Journal of clinical oncology 23 (7), 1390-1400, 2005 | 115 | 2005 |
Information from the Internet: attitudes of Australian oncology patients GM Newnham, WI Burns, RD Snyder, AJ Dowling, NF Ranieri, EL Gray, ... Internal medicine journal 36 (11), 718-723, 2006 | 95 | 2006 |
“Cast Adrift” The Experience of Completing Treatment Among Women with Early Stage Breast Cancer CE Lethborg, D Kissane, WI Burns, R Snyder Journal of Psychosocial Oncology 18 (4), 73-90, 2000 | 95 | 2000 |
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2 … M Martin, H Roche, T Pinter, J Crown, MJ Kennedy, L Provencher, F Priou, ... The lancet oncology 12 (4), 369-376, 2011 | 83 | 2011 |
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer MD Green, PA Francis, V Gebski, V Harvey, C Karapetis, A Chan, ... Annals of Oncology 20 (11), 1813-1817, 2009 | 76 | 2009 |
Attitudes of oncology health professionals to information from the Internet and other media GM Newnham, WI Burns, RD Snyder, AJ Dowling, NF Ranieri, EL Gray, ... Medical Journal of Australia 183 (4), 197-200, 2005 | 74 | 2005 |
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up JA Levi, D Thomson, T Sandeman, M Tattersall, D Raghavan, M Byrne, ... J Clin Oncol 6 (7), 1154-1160, 1988 | 74 | 1988 |
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX S Aebi, Z Sun, D Braun, KN Price, M Castiglione-Gertsch, M Rabaglio, ... Annals of oncology 22 (9), 1981-1987, 2011 | 71 | 2011 |
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast … PG Gill, V Gebski, R Snyder, I Burns, J Levi, M Byrne, A Coates Annals of oncology 4 (9), 741-744, 1993 | 52 | 1993 |
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study DM Hyams, A Chan, C de Oliveira, R Snyder, J Vinholes, MW Audeh, ... Investigational new drugs 31, 1345-1354, 2013 | 41 | 2013 |
Adenocarcinoma of unknown primary site: A clinico‐pathological study RD Snyder, GM Mavligit, M Valdivieso Medical and Pediatric Oncology 6 (4), 289-294, 1979 | 35 | 1979 |
Backsplinting for treatment of thoracic and lumbar fracture/luxation in the dog: principles of application and case series RH Patterson, GK Smith Veterinary and Comparative Orthopaedics and Traumatology 5 (04), 179-187, 1992 | 29 | 1992 |